Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling

[1]  J. Chun,et al.  Lysophospholipid receptors: signaling and biology. , 2004, Annual review of biochemistry.

[2]  J. Chun,et al.  Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding , 2003, Nature Neuroscience.

[3]  H. Ueda,et al.  Novel Expression of Vanilloid Receptor 1 on Capsaicin-Insensitive Fibers Accounts for the Analgesic Effect of Capsaicin Cream in Neuropathic Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.

[4]  J. Chun,et al.  Lysophosphatidic acid in neural signaling. , 2002, Neuroreport.

[5]  J. Chun,et al.  Neurobiology of lysophosphatidic acid signaling. , 2002, The Neuroscientist.

[6]  N. Calcutt,et al.  Injury Type-Specific Calcium Channel α2δ-1 Subunit Up-Regulation in Rat Neuropathic Pain Models Correlates with Antiallodynic Effects of Gabapentin , 2002, Journal of Pharmacology and Experimental Therapeutics.

[7]  S. McMahon,et al.  BDNF: a neuromodulator in nociceptive pathways? , 2002, Brain Research Reviews.

[8]  J. Chun,et al.  Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) Lysophosphatidic Acid Receptor Knockout Mice: Signaling Deficits without Obvious Phenotypic Abnormality Attributable to lpa2 , 2002, Molecular and Cellular Biology.

[9]  J. Eisenach,et al.  Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain , 2002, The European journal of neuroscience.

[10]  J. Weiner,et al.  Regulation of Schwann Cell Morphology and Adhesion by Receptor-Mediated Lysophosphatidic Acid Signaling , 2001, The Journal of Neuroscience.

[11]  L. Sorkin,et al.  Upregulation of Dorsal Root Ganglion α2δ Calcium Channel Subunit and Its Correlation with Allodynia in Spinal Nerve-Injured Rats , 2001, The Journal of Neuroscience.

[12]  W D Willis,et al.  Role of Neurotransmitters in Sensitization of Pain Responses , 2001, Annals of the New York Academy of Sciences.

[13]  J. Cui,et al.  Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy , 2000, PAIN.

[14]  J. Weiner,et al.  Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Chun,et al.  Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. , 2000, Molecular pharmacology.

[16]  K. Bowen,et al.  Loose ligation of the rat sciatic nerve is accompanied by changes in the subcellular content of protein kinase C beta II and gamma in the spinal dorsal horn , 2000, Neuroscience Letters.

[17]  Christian Broberger,et al.  Neuropeptides — an overview , 2000, Neuropharmacology.

[18]  M. Inoue,et al.  Botulinum toxin C3 inhibits hyperalgesia in mice with partial sciatic nerve injury. , 2000, Japanese journal of pharmacology.

[19]  H. Ueda,et al.  Vzg-1/lysophosphatidic acid-receptor involved in peripheral pain transmission. , 2000, Brain research. Molecular brain research.

[20]  S. Fleetwood-Walker,et al.  VIP and PACAP: very important in pain? , 1999, Trends in pharmacological sciences.

[21]  S. McMahon,et al.  Causes and consequences of sympathetic basket formation in dorsal root ganglia , 1999, Pain.

[22]  H. Ueda,et al.  Lysophosphatidic acid-induced, pertussis toxin-sensitive nociception through a substance P release from peripheral nerve endings in mice , 1999, Neuroscience Letters.

[23]  G. Bennett,et al.  Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies? , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Fiorentini,et al.  Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. , 1999, Molecular biology of the cell.

[25]  C. Woolf,et al.  Neuropathic pain: aetiology, symptoms, mechanisms, and management , 1999, The Lancet.

[26]  J. Weiner,et al.  Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Ueda.  In vivo molecular signal transduction of peripheral mechanisms of pain. , 1999, Japanese journal of pharmacology.

[28]  T D Bird,et al.  Neuropathic pain in Charcot-Marie-Tooth disease. , 1998, Archives of physical medicine and rehabilitation.

[29]  J. Chun,et al.  A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Basbaum,et al.  Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates , 1998, Pain.

[31]  D. G. Green,et al.  Serum‐induced changes in the physiology of mammalian retinal glial cells: role of lysophosphatidic acid , 1998, The Journal of physiology.

[32]  Shuh Narumiya,et al.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.

[33]  S. Tonegawa,et al.  Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. , 1997, Science.

[34]  U. Suter,et al.  Heterozygous Peripheral Myelin Protein 22-Deficient Mice Are Affected by a Progressive Demyelinating Tomaculous Neuropathy , 1997, The Journal of Neuroscience.

[35]  J. Weiner,et al.  Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex , 1996, The Journal of cell biology.

[36]  W. Willis,et al.  Possible Role of Protein Kinase C in the Sensitization of Primate Spinothalamic Tract Neurons , 1996, The Journal of Neuroscience.

[37]  D. Price,et al.  Increases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy , 1995, Neuroscience Letters.

[38]  B. Pentland,et al.  Pain in the Guillain-Barré syndrome: a clinical review , 1994, Pain.

[39]  I. Fahrenfort,et al.  The bioactive phospholipid lysophosphatidic acid is released from activated platelets. , 1993, The Biochemical journal.

[40]  K. Schumacher,et al.  Platelet Aggregation Evoked In Vitro and In Vivo by Phosphatidic Acids and Lysoderivatives: Identity with Substances in Aged Serum (DAS) , 1979, Thrombosis and Haemostasis.

[41]  A. Mahapatra,et al.  Mechanisms of Neuropathic Pain , 2018 .

[42]  J. Weiner,et al.  Lysophospholipid receptors. , 2001, Annual review of pharmacology and toxicology.